Cambridge, UK, March 02 2023: The o2h group, a company based out of Ahmedabad, India and Cambridge, UK, which has a track record of nurturing and investing in emerging life science and tech companies, hosted the 5th edition of the o2h Collaborative Innovation Conference in Ahmedabad on Thursday. The conference brought together participants from the fields of science, technology, investment, and business for discussions on ways to enhance collaboration for innovation.
The o2h collaborative innovation conference covered a range of topics, including investment strategies, decentralised science and blockchain, public policy, technology, business strategy, company responsibility, and more. The discussions at the conference, however, were not just related to subjects covering science and technology, but also much broader people, societal and environmental issues.
Sunil Parekh, Senior Strategy Advisor at Zydus and Jubilant, Priya Mande, COO and Board Director at PsiOxus Therapeutics, Abhay Mangaldas Founder of The House of Mangaldas Girdhardas, Nirmit Kothari, Director at Deloitte, Megha Bhatt, Founder of SciKnowTech, Akshay Gupta, racing driver turned entrepreneur, and Tanmaye Vyas of Astronomy Club were among the national and international speakers who shared their insights at the conference.
Prashant Shah, Co-Founder & Co-CEO of the o2h group, said: “We love seeding new ideas in o2h in life science, tech and green innovation so we can impact human and planet health. As we know it’s not always the biggest companies, financiers and governments alone that drive innovation and creativity but by working genuinely collaboratively with the changemakers, dreamers, entrepreneurs, scientists, techies, artists, academics, journalists, experts, activists, residents and small investors, in cultures, that give generously to the nurturing of their clusters, that we can make a difference.”
The o2h group believes that by working with others, and using ‘all the brains’ we create opportunities for convergence and the cross fertilisation of ideas across boundaries where we can spur real innovation that shapes the future, and also powers an economy. We are passionate about playing our part in the creation of a community of changemakers and innovators connecting the ecosystems of Ahmedabad, Cambridge, UK and the USA East Coast & West Coast.
The vision of o2h group is to be the best at seeding new ideas in life science, technology and green innovation by co-investing, co-creating and co-executing across boundaries. It seeds new ideas by triaging funding, execution and incubation. It has an impressive track record of breakthrough innovations in people, processes, and technologies over the past decade.
About o2h group
The o2h group was founded in 2005, with the vision to seed new ideas in life science, technology, and green innovation. We work across boundaries and take a collaborative and shared approach to innovation; therefore, we co-invest, co-create, and co-execute to bring these ideas to life. The divisions include funding, incubation and execution covering chemistry, biology and tech.
The o2h group is co-located in Cambridge, UK and in Ahmedabad, India and has 6 verticals covering Venture, discovery, technology, co-work, community and therapeutics.
o2h Ventures – An engine for nurturing early stage life-science and technology assets through seed investment.
o2h discovery – An integrated chemistry and biology services capability for collaborative research.
o2h technology – A multi-function, multi-platform technology capability for building proprietary software tools and companies.
o2h co-work labs – A co-working space in Hauxton, Cambridge for entrepreneurs, scientists, techies & dreamers.
o2h community – We work with non-profit, social enterprise and hold events supporting women in science & tech and collaborative innovation.
o2h therapeutics – A novel pipeline of proprietary preclinical IP in oncology (glioblastoma, breast cancer), anti-ageing and diabetes.
For more information, please see – www.o2h.com
About Prashant Shah
Prashant is the CEO of o2h co-work labs, a general partner of the o2h Ventures seed funds, the Co-CEO of o2h discovery and the Co-Founder of the o2h group.
As a serial entrepreneur from the dot-com era now covering life-science and tech he co-founded a drug discovery company that was acquired by a major public company. He is an active ecosystem, community and culture builder and interests include seed investing (a portfolio of almost 50 companies), services and product/IP development.
Prashant began his career with the strategy group of Accenture in London working across various industry groups. He is an author and has a BEng, an MSc and an MPhil in Management from the University of Cambridge.
About Sunil Shah
Sunil has co-founded the o2h group, this includes o2h Ventures, an HMRC approved ‘ Human Health’ Knowledge Intensive EIS fund; o2h discovery, a medicinal chemistry research services company and o2h co-work labs. He is an entrepreneur having begun his career in the Life Sciences team at PA Consulting. He co-founded Oxygen Healthcare Ltd which was fully acquired by Piramal Enterprises Ltd (BSE: PEL) in 2013.
Sunil is either Chairman, Non-Executive Director, Board Observer or an Investor in over 20 Biotech companies in the UK and has won several awards for his significant contribution in the Life Sciences Industry. Sunil has a degree in Biochemistry from Keele and an MBA from Cambridge University.